NORTH CHICAGO, Illinois., November 9, 2022 /PRNewswire/ — Rosalind Franklin University of Medicine and Science announces the launch of its new BioInnovations Speaker Series, which debuted on October 19 in person at RFU Innovation and Research Park (IRP) and live via Zoom with “Advances in the Diagnosis, Prevention and Treatment of Brain Diseases”.
Industry panelists included Jim SullivanPhD, CEO of Vanqua Bio; Murali Gopalakrishnan, PhD, Global Head, Neuroscience Research and Evaluation at AbbVie; and several senior faculty researchers from RFU’s Brain Science Institute, including Director Amiel Rosenkranz, PhD, who moderated the session. According to Dr. Rosenkranz, more than 2 billion people worldwide are affected by brain disorders, including 1 in 6 in the United States, where neurological disorders are expensive. $1 trillion or more per year.
The series will continue December 7 of 4:30-6:30 p.m. with “Stress and its links with mental and physical health disorders”, hosted by Kristin L.Schneider, PhD, Associate Dean for Research at the RFU College of Health Professions. Panelists will include Chicago Medical School assistant professor Joanna Dabrowska, PhD, PharmD, whose lab studies how repeated stress can lead to long-term changes in stress coping behavior; Associate Professor of Psychology Monika Waszczuk, PhD, who has studied the impact of trauma exposure on health outcomes, including 9/11 first responders; and Associate Professor of Psychology Brian A. FeinsteinPhD, who studies the importance of mental health in people from sexual and gender minorities.
Industry panelists on December 7 will include Katherine LeaderbrandPhD, Associate Director for Research at Aptinyx, Inc.; Ethel Larson, Vice President and General Manager, Head of Psychiatry Business Unit for Lundbeck; and Venoncia M. Baté-Ambrus, PhD, Executive Director of the Healthcare Foundation of North Lake County.
The first event of 2023, “Industrial and Academic Collaborations”, is scheduled for February 15. All events in the series are free and open to IRP partners and supporters; industry leaders and biomedical entrepreneurs; the RFU campus community, including scholars and alumni; and the general public.
“This exciting new speaker series, in partnership with Lake County Partners, will discuss key global health and biomedical research issues that impact society, including industry and academic researchers,” said Ronald KaplanPhD, Executive Vice President of Research at RFU.
ABOUT RFU: RFU comprises six colleges and more than 10 research centers and institutes. Learn more about rosalindfranklin.edu.
Contact: [email protected]
THE SOURCE Rosalind Franklin University of Medicine and Science